BioCentury
ARTICLE | Clinical News

DHEA: Phase III

May 11, 1998 7:00 AM UTC

The hormone is thought to act as a neuroprotective agent by increasing growth factor levels and modulating inflammatory cytokines in the brain. Results are expected by year end. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article